Effectiveness of different immunoadsorption columns for anti-A/B antibody depletion
- 1 December 2019
- journal article
- research article
- Published by Elsevier in Atherosclerosis Supplements
- Vol. 40, 68-72
Abstract
No abstract availableKeywords
Funding Information
- Fresenius Biotech
This publication has 9 references indexed in Scilit:
- Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patientsAmerican Journal of Transplantation, 2018
- IgG Endopeptidase in Highly Sensitized Patients Undergoing TransplantationNew England Journal of Medicine, 2017
- ABO-Incompatible Kidney TransplantationFrontiers in Immunology, 2017
- Outcomes Following ABO-Incompatible Kidney Transplantation Performed After Desensitization by Nonantigen-Specific ImmunoadsorptionTransplantation, 2015
- Antigen-Specific versus Non-Antigen-Specific Immunoadsorption in ABO-Incompatible Renal TransplantationPLOS ONE, 2015
- Three-Year Outcomes Following 1420 ABO-Incompatible Living-Donor Kidney Transplants Performed After ABO Antibody ReductionTransplantation, 2015
- AB0 incompatible kidney transplantation using unspecific immunoadsorptionTransfusion and Apheresis Science, 2014
- ABO-Incompatible Kidney Transplantation Enabled by Non-Antigen-Specific ImmunoadsorptionTransplantation, 2012
- Anti-A/B antibody depletion by semiselective versus ABO blood group-specific immunoadsorptionNephrology Dialysis Transplantation, 2011